Hamilton Thorne Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HTL.V research report →
Companywww.hamiltonthorne.ltd
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets under the Hamilton Thorne brand; test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services under the Embryotech brand.
- CEO
- David B. Wolf
- IPO
- 2012
- HQ
- Beverly, MA, US
Price Chart
Valuation
- Market Cap
- $212.88M
- P/E
- -395.06
- P/S
- 3.73
- P/B
- 3.71
- EV/EBITDA
- 48.71
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 50.35%
- Op Margin
- 0.41%
- Net Margin
- -0.90%
- ROE
- -1.00%
- ROIC
- 0.15%
Growth & Income
- Revenue
- $52.35M · 31.61%
- Net Income
- $2.43M · 150.62%
- EPS
- $0.02 · 100.00%
- Op Income
- $3.82M
- FCF YoY
- -21.21%
Performance & Tape
- 52W High
- $1.73
- 52W Low
- $1.05
- 50D MA
- $1.38
- 200D MA
- $1.51
- Beta
- 0.54
- Avg Volume
- 22.21K
Get TickerSpark's AI analysis on HTL.V
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HTL.V Coverage
We haven't published any research on HTL.V yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HTL.V Report →